Newspapers / Q-notes (Charlotte, N.C.) / Jan. 15, 2005, edition 1 / Page 10
Part of Q-notes (Charlotte, N.C.) / About this page
This page has errors
The date, title, or page description is wrong
This page has harmful content
This page contains sensitive or offensive material
10 Q-NOTES • JANUARY 15 . 2005 :r r > ■ TREATMENT FOR EVERYDAY LIVING Truvada INDICATION: TRUVADA is for use in combination with other anti-HIV agents to treat HIV infection in adults. TRUVADA contains 2 medicines, EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate) combined in one tablet. • EMTRIVA and VIREAD have been studied separately. Clinical studies with TRUVADA and EMTRIVA-eVIREAD are ongoing. • Since EMTRIVA and Epivir (3TC) are similar medicines, studies using VIREAD-h 3TC support the use of TRUVADA. Therefore, TRUVADA should be considered as an alternative to the combination of VIREAD-t-EMTRIVA or VIREAD-f-Epivir® for someone who would benefit from a once-a-day regimen. • TRUVADA does not cure HIV infection. No studies show the effect of TRUVADA on the clinical progression of HIV. TRUVADA should not be used as part of a triple nucleoside regimen. IMPORTANT SAFEH INFORMATION: • Lactic acidosis (a buildup of acid in the blood) can be a medical emergency and may need to be treated in the hospital. Call your medical professional right away if you have nausea, vomiting, unusual muscle pain, and/or weakness.
Q-notes (Charlotte, N.C.)
Standardized title groups preceding, succeeding, and alternate titles together.
Jan. 15, 2005, edition 1
10
Click "Submit" to request a review of this page. NCDHC staff will check .
0 / 75